Nitric oxide inhibits the adenovirus proteinase in vitro and viral infectivity in vivo - PubMed (original) (raw)

. 2003 Dec;17(15):2345-6.

doi: 10.1096/fj.03-0396fje. Epub 2003 Oct 2.

Affiliations

Nitric oxide inhibits the adenovirus proteinase in vitro and viral infectivity in vivo

Wangsen Cao et al. FASEB J. 2003 Dec.

Abstract

Nitric oxide (NO) is an antiviral effector of the innate immune system, but few of the viral targets of NO have been identified. We now show that NO inhibits adenovirus replication by targeting the adenovirus proteinase (AVP). NO generated from diethylamine NONOate (DEA-NONOate) or spermine NONOate (Sp-NONOate) inhibited the AVP. Inhibition was reversible with dithiothreitol. The equilibrium dissociation constant for reversible binding to the AVP by Sp-NONOate, or Ki, was 0.47 mM, and the first-order rate constant for irreversible inhibition of the AVP by Sp-NONOate, or ki, was 0.0036 s(-1). Two hallmarks of a successful adenovirus infection were abolished by the NO donors: the appearance of E1A protein and the cleavage of cytokeratin 18 by AVP. Treatment of infectious virus by DEA-NONOate dramatically decreased viral infectivity. These data suggest that NO may be a useful antiviral agent against viruses encoding a cysteine proteinase and in particular may be an antiadenovirus agent.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

Substances

LinkOut - more resources